Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Return on Assets (2016 - 2025)

Fortress Biotech has reported Return on Assets over the past 13 years, most recently at 0.3% for Q4 2025.

  • Quarterly results put Return on Assets at 0.3% for Q4 2025, up 56.0% from a year ago — trailing twelve months through Dec 2025 was 0.3% (up 56.0% YoY), and the annual figure for FY2025 was 0.2%, up 57.0%.
  • Return on Assets for Q4 2025 was 0.3% at Fortress Biotech, up from 0.44% in the prior quarter.
  • Over the last five years, Return on Assets for FBIO hit a ceiling of 0.28% in Q1 2021 and a floor of 1.06% in Q3 2023.
  • Median Return on Assets over the past 5 years was 0.64% (2025), compared with a mean of 0.63%.
  • Biggest five-year swings in Return on Assets: tumbled -44bps in 2023 and later soared 56bps in 2025.
  • Fortress Biotech's Return on Assets stood at 0.46% in 2021, then crashed by -47bps to 0.67% in 2022, then plummeted by -37bps to 0.92% in 2023, then grew by 7bps to 0.85% in 2024, then skyrocketed by 65bps to 0.3% in 2025.
  • The last three reported values for Return on Assets were 0.3% (Q4 2025), 0.44% (Q3 2025), and 0.65% (Q2 2025) per Business Quant data.